Sponsor pipeline

Qilu Hospital of Shandong University clinical trial pipeline

Get alerts when Qilu Hospital of Shandong University's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

6 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 5 with minor changes only.

Show 5 trials with minor changes only
  2. Minor
    4 trials marked Unknown by the registry's verification sweep

    Registry verification sweep

    Changed

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-14 NCT07873060 Comparing 10 Hz rTMS and iTBS for Adolescent Depression Recruiting
2026-09-21 NCT07831551 EECP for Erectile Dysfunction in Elderly Hypertensive Patients Not Yet Recruiting
2026-09-21 NCT07832188 A Study on the Efficacy of Dual-Carrier-Frequency Transcranial Alternating Current… Recruiting

Active trials by phase

Early Phase 1
4
Phase 1
3
Phase 1/2
1
Phase 2
17
Phase 2/3
1
Phase 4
8
Not charted: 101 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 135

NCT IDTitleConditionStatusUpdated
Phase 4
NCT04728516 The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients Acute Coronary Syndrome Recruiting 2025-09-16
NCT06699420 Qishenyiqi Dripping Pill for Coronary Microvascular Disease Coronary Microvascular Disease Recruiting 2024-11-21
NCT06092736 Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS) Microvascular Angina Recruiting 2023-10-23
NCT05626348 The Clinical Efficacy of Immunomodulators in RA Patients Arthritis, Rheumatoid Recruiting 2022-11-29
NCT07757919 Efficacy and Safety of 14-Day Vonoprazan-Minocycline Dual Therapy for Helicobacter Pylori… HELICOBACTER PYLORI INFECTIONS Not Yet Recruiting 2026-08-11
NCT07750938 Optimizing H. Pylori Eradication Regimen Under Intensified Acid Suppression HELICOBACTER PYLORI INFECTIONS Not Yet Recruiting 2026-08-06
NCT06727890 Compound Danshen Dripping Pill for Diabetic Microvascular Angina Diabetic Microvascular Angina Not Yet Recruiting 2024-12-11
NCT06699407 Qishenyiqi for Ventricular Remodeling After Myocardial Infarction Chronic Stable Heart Failure Not Yet Recruiting 2024-11-21
Phase 2/3
NCT06678685 Spironolactone Improved Children With Gene Mutations Related to NCOR NCOR Gene Mutations Recruiting 2026-05-18
Phase 2
NCT07089199 Tislelizumab Combined With Anlotinib and Nab-paclitaxel in II-III Resectable Non-small… NSCLC Recruiting 2026-10-13
NCT06730373 First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2) HER2-positive Gastric Cancer Recruiting 2026-09-15
NCT06932068 Phase II Trial of Iparomlimab/Tuvonralimab (QL1706) + XELOX in HER2-Negative, Low PD-L1… HER2 Negative Recruiting 2026-05-07
NCT07537348 Safety and Efficacy of Leucine-Restricted Diet Combined With Chemotherapy and… Advanced Gastric Cancer Recruiting 2026-04-17
NCT07537361 Safety and Efficacy of Leucine-Restricted Diet Combined With Neoadjuvant Chemotherapy and… Gastric Cancer Recruiting 2026-04-17
NCT07264803 A Single-arm Clinical Trial Using Patient-derived Tumor Tissue Fragment Models for Drug… Solid Tumor Malignancies Recruiting 2025-12-04
NCT06735326 Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer Ovarian Cancer Recruiting 2024-12-16
NCT06454578 Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence… Carcinoma, Hepatocellular Recruiting 2024-08-01
NCT06242067 Second-line Treatment of Metastatic Colorectal Cancer Metastatic Colorectal Cancer Recruiting 2024-02-05
NCT05585580 Second-line Treatment With Serplulimab, Lenvatinib, and Paclitaxel in Advanced Gastric… Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Active, Not Recruiting 2026-05-26
NCT07201675 Vedisertib (RC48/ADC) Combined With Toripalimab in Bladder-preserving Treatment Muscle Invasive Bladder Cancer (MIBC) Not Yet Recruiting 2025-10-01
NCT07172217 The Efficacy and Safety RC48 Plus QL1706 in Second-Line Treatment of HER2-Expressing… Recurrent Cervical Cancer Not Yet Recruiting 2025-09-15
NCT07156682 QL1706 Plus XELOX as Neoadjuvant Therapy for MSS/pMMR Clinical Stage III Colon Cancer Colon Cancer Not Yet Recruiting 2025-09-05
NCT06880926 Antarctic Krill Oil for Knee Osteoarthritis Pain Osteoarthritis (OA) of the Knee Not Yet Recruiting 2025-03-18
NCT05586061 First-line Treatment with RC48 Plus Tislelizumab and S-1(RCTS) in Advanced Gastric Cancer HER2-positive Gastric Cancer Active, Not Recruiting 2025-02-07
NCT06239532 HAIC Sequential TAE Combined With Tislelizumab and Surufatinib in Unresectable… Intrahepatic Cholangiocarcinoma Active, Not Recruiting 2024-11-21
See all 135 active Qilu Hospital of Shandong University trials with filters →

Disease areas by active trials, top 10 of 33

Heart Disease (20) · Gastric Cancer (14) · Bladder Cancer (7) · Stroke (7) · Coronary Artery Disease (6) · Ulcerative Colitis (4) · Cervical Cancer (3) · Colorectal Cancer (3) · Heart Failure (3) · ADHD (2)

Get alerts when Qilu Hospital of Shandong University's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free